Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GILD | AMGN | CELG | BIIB | REGN |
| Company | Gilead Sciences Inc | Amgen Inc | Celgene Corp | Biogen Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 84.39 | 337.03 | 108.01 | 200.57 | 1,149.66 |
| High | 84.65 | 338.70 | 108.59 | 204.18 | 1,165.85 |
| Low | 83.57 | 334.61 | 107.27 | 200.11 | 1,148.13 |
| Last | 83.93 | 336.58 | 108.24 | 201.85 | 1,161.60 |
| Change | +0.04 | +3.66 | +0.11 | +4.26 | +22.79 |
| % Change | +0.05% | +1.10% | +0.10% | +2.16% | +2.00% |
| Volume | 1,776,549 | 345,178 | 191,230,496 | 298,023 | 220,381 |
| 20-Day Average Volume | 6,336,320 | 1,695,954 | 16,188,930 | 785,911 | 401,126 |
| Previous Close | 83.89 | 332.92 | 108.13 | 197.59 | 1,138.81 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | No | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 80.07 | 329.63 | 108.17 | 201.67 | 1,166.11 |
| 20-Day Raw Stochastic | 90.25% | 89.10% | 63.25% | 72.57% | 49.87% |
| 20-Day Relative Strength | 71.99% | 58.31% | 64.69% | 46.96% | 55.37% |
| Weighted Alpha | +18.35 | +27.55 | +46.30 | -20.91 | +43.15 |
| Today's Opinion | 88% Buy | 96% Buy | 100% Buy | 88% Sell | 80% Buy |
| Previous Opinion | 88% Buy | 88% Buy | 100% Buy | 100% Sell | 80% Buy |
| Last Month's Opinion | 56% Buy | 88% Buy | 100% Buy | 88% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.96% since 09/12/24 | +2.05% since 09/12/24 | -1.97% since 11/13/19 | +2.47% since 09/12/24 | -0.20% since 09/12/24 |
| Low | 81.57 on 09/13/24 | 327.15 on 09/13/24 | 107.27 on 11/20/19 | 192.25 on 09/13/24 | 1,134.59 on 09/17/24 |
| High | 84.61 on 09/19/24 | 339.00 on 09/18/24 | 110.53 on 11/14/19 | 204.18 on 09/19/24 | 1,170.58 on 09/13/24 |
| 1-Month | |||||
| %Chg | +12.77% since 08/19/24 | +2.70% since 08/19/24 | +5.14% since 10/18/19 | -1.59% since 08/19/24 | -2.91% since 08/19/24 |
| Low | 74.34 on 08/20/24 | 319.00 on 09/06/24 | 102.40 on 10/21/19 | 192.25 on 09/13/24 | 1,113.24 on 09/11/24 |
| High | 84.89 on 09/12/24 | 339.00 on 09/18/24 | 110.70 on 11/13/19 | 207.59 on 08/21/24 | 1,211.20 on 08/27/24 |
| 3-Month | |||||
| %Chg | +32.95% since 06/18/24 | +10.08% since 06/18/24 | +13.63% since 08/20/19 | -9.33% since 06/18/24 | +11.84% since 06/18/24 |
| Low | 64.86 on 06/20/24 | 303.55 on 06/20/24 | 93.41 on 08/23/19 | 192.25 on 09/13/24 | 1,011.67 on 07/03/24 |
| High | 84.89 on 09/12/24 | 346.85 on 07/25/24 | 110.70 on 11/13/19 | 238.00 on 07/12/24 | 1,211.20 on 08/27/24 |
| 6-Month | |||||
| %Chg | +14.37% since 03/19/24 | +23.95% since 03/19/24 | +14.14% since 05/20/19 | -7.25% since 03/19/24 | +20.59% since 03/19/24 |
| Low | 62.07 on 05/31/24 | 260.68 on 04/19/24 | 89.08 on 07/23/19 | 189.44 on 04/19/24 | 875.22 on 04/26/24 |
| High | 84.89 on 09/12/24 | 346.85 on 07/25/24 | 110.70 on 11/13/19 | 238.00 on 07/12/24 | 1,211.20 on 08/27/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 104,514,608 | 178,589,936 | 77,035,920 | 28,768,510 | 125,480,912 |
| Shares Outstanding, K | 1,245,853 | 536,435 | 711,714 | 145,597 | 110,186 |
| Annual Sales | 27,116,000,000 | 28,190,000,000 | 15,281,000,000 | 9,835,600,000 | 13,117,200,000 |
| Annual Net Income | 5,665,000,000 | 6,717,000,000 | 4,046,000,000 | 1,161,100,000 | 3,953,600,000 |
| Last Quarter Sales | 6,954,000,000 | 8,388,000,000 | 4,520,000,000 | 2,464,900,000 | 3,547,100,000 |
| Last Quarter Net Income | 1,614,000,000 | 746,000,000 | 1,691,000,000 | 583,600,000 | 1,432,300,000 |
| 60-Month Beta | 0.18 | 0.61 | 1.41 | -0.06 | 0.12 |
| Per-Share Information | |||||
| Most Recent Earnings | 2.01 on 08/08/24 | 4.97 on 08/06/24 | 2.99 on 10/31/19 | 5.28 on 08/01/24 | 11.56 on 08/01/24 |
| Latest Earnings Date | 11/05/24 | 10/29/24 | 10/31/19 | 08/01/24 | 11/07/24 |
| Most Recent Dividend | 0.770 on 09/13/24 | 2.250 on 08/16/24 | N/A | N/A | N/A |
| Next Ex-Dividends Date | 09/13/24 | 08/16/24 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 17.67 | 17.89 | 10.99 | 12.19 | 29.85 |